Evidence map›Paper›PMID 35595779›Full record

ArticleCell death discovery2022

Regulation of BDNF transcription by Nrf2 and MeCP2 ameliorates MPTP-induced neurotoxicity.

Qianqian Cao, Qiuming Zou, Xin Zhao, Yimin Zhang, Youge Qu, Nanbu Wang, Shigeo Murayama, Qi Qi, Kenji Hashimoto, Song Lin and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cell death discovery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. BDNF/TrkB activators in Parkinson's disease: A new therapeutic strategy.Journal of cellular and molecular medicine · 2024
    Review
  13. Article
  14. Article
  15. Review
  16. Epigenetics in rare neurological diseases.Frontiers in cell and developmental biology · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Qianqian Cao *Department of Physiology, School of Medicine, Jinan University, 510632, Guangzhou, China.
Qiuming Zou *Department of Pharmacology, School of Medicine, Jinan University, 510632, Guangzhou, China.
Xin Zhao *Department of Physiology, School of Medicine, Jinan University, 510632, Guangzhou, China.
Yimin Zhang *Department of Physiology, School of Medicine, Jinan University, 510632, Guangzhou, China.
Youge QuDivision of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, 260-8670, Japan.
Nanbu WangThe First Affiliated Hospital of Guangzhou University of Chinese Medicine, 510632, Guangzhou, China.
Shigeo MurayamaDepartment of Neuropathology (Brain Bank for Aging Research), Tokyo Metropolitan Geriatric Hospital & Institute of Gerontology, Tokyo, 173-0015, Japan.
Qi QiDepartment of Pharmacology, School of Medicine, Jinan University, 510632, Guangzhou, China.ORCID http://orcid.org/0000-0003-4460-0713
Kenji HashimotoDivision of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, 260-8670, Japan. hashimoto@faculty.chiba-u.jp.ORCID http://orcid.org/0000-0002-8892-0439
Song LinDepartment of Physiology, School of Medicine, Jinan University, 510632, Guangzhou, China. linsong@jnu.edu.cn.ORCID http://orcid.org/0000-0003-0489-9239
Ji-Chun ZhangDepartment of Physiology, School of Medicine, Jinan University, 510632, Guangzhou, China. jczhang@jnu.edu.cn.ORCID http://orcid.org/0000-0001-6035-6867
Jinan University · CNCenter for Forensic Mental Health, Chiba University · JPFirst Affiliated Hospital of Guangzhou University of Chinese Medicine · CNTokyo Metropolitan Geriatric Hospital · JP

Funding

MEXT | Japan Society for the Promotion of Science (JSPS) 17H04243National Natural Science Foundation of China (National Science Foundation of China) 31900825National Natural Science Foundation of China (National Science Foundation of China) 81973341
6 · The paper itself

Abstract

Mounting evidence suggests the key role of brain-derived neurotrophic factor (BDNF) in the dopaminergic neurotoxicity of Parkinson's disease (PD). Activation of NF-E2-related factor-2 (Nrf2) and inhibition of methyl CpG-binding protein 2 (MeCP2) can regulate BDNF upregulation. However, the regulation of BDNF by Nrf2 and MeCP2 in the PD pathogenesis has not been reported. Here, we revealed that Nrf2/MeCP2 coordinately regulated BDNF transcription, reversing the decreased levels of BDNF expression in 1-methyl-4-phenylpyridinium (MPP

Identifiers

PMID35595779
PMCPMC9122988
OpenAlexW4280535756

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.